News Focus
News Focus
icon url

Bu33ard

08/22/20 11:17 AM

#12393 RE: randychub #12385

From the Article in Bio-World

"The FDA also granted an expanded access protocol for RLF-100 (aviptadil), from Geneva-based Relief Therapeutics Holdings AG and Radnor, Pa.-based Neurorx Inc., to those patients who are ineligible for enrollment in clinical trials"

Very good news.
icon url

cjstocksup

08/22/20 1:02 PM

#12423 RE: randychub #12385

RLFTF Aviptadil is mentioned in Bio World
"The FDA also granted an expanded access protocol for RLF-100 (aviptadil), from Geneva-based Relief Therapeutics Holdings AG and Radnor, Pa.-based Neurorx Inc., to those patients who are ineligible for enrollment in clinical trials"
https://www.google.com/url?rct=j&sa=t&url=https://www.bioworld.com/articles/496885-five-nmes-approved-in-july-covid-19-data-is-17&ct=ga&cd=CAEYACoTODUxNzkxMjI4MTA3NjMxNDQ1MjIaNDZmNjY2OTVmNzM4NDQ0NDpjb206ZW46VVM&usg=AFQjCNHlVsNSdWxf-DwsA-n0Kxzw5RW27g